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Abstract
Aims/hypothesis The aim of this work was to determine
whether placental endoplasmic reticulum (ER) stress may
contribute to the pathophysiology of gestational diabetes
mellitus (GDM) and to test the efficacy of chemical chaper-
ones and antioxidant vitamins in ameliorating that stress in a
trophoblast-like cell line in vitro.
Methods Placental samples were obtained from women suf-
fering from GDM and from normoglycaemic controls and
were frozen immediately. Women with GDM had 2 h serum
glucose levels > 9.0 mmol/l following a 75 g oral glucose
tolerance test and were treated with diet and insulin when
necessary. Western blotting was used to assess markers of
ER stress. To test the effects of hyperglycaemia on the gener-
ation of ER stress, a new trophoblast-like cell line, BeWo-NG,
was generated by culturing in a physiological glucose concen-
tration of 5.5 mmol/l (over 20 passages) before challenging
with 10 or 20 mmol/l glucose.
Results All GDM patients were well-controlled (HbA1c 5.86
±0.55% or 40.64±5.85 mmol/mol, n=11). Low-grade ER
stress was observed in the placental samples, with dilation of
ER cisternae and increased phosphorylation of eukaryotic ini-
tiation factor 2 subunit α. Challenge of BeWo-NG with high
glucose activated the same pathways, but this was as a result
of acidosis of the culture medium rather than the glucose con-
centration per se. Addition of chemical chaperones 4-
phenylbutyrate and tauroursodeoxycholic acid and vitamins
C and E ameliorated the ER stress.
Conclusions/interpretation This is the first report of placental
ER stress in GDM patients. Chemical chaperones and antiox-
idant vitamins represent potential therapeutic interventions for
GDM.
Keywords Antioxidants . Chaperones . Endoplasmic
reticulum stress . Gestational diabetes .Metabolic acidosis .
Placenta . Trophoblast . Unfolded protein response
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Introduction
Gestational diabetes mellitus (GDM) is a subtype of diabetes
that arises de novo late in the second trimester or early in the
third trimester of pregnancy. It represents a global health
challenge, with incidences reaching 17.8% of total pregnancies
[1]. Predisposing factors include maternal obesity, metabolic
dysfunction and genetic susceptibility. Although the
mechanisms are not fully understood, decreased insulin
sensitivity and inadequate insulin secretion are two common
causative factors. Women with GDM are at increased risk of
developing other complications of pregnancy, including
pregnancy-induced hypertension and pre-eclampsia [2]. They
also have an increased lifetime risk for type 2 diabetes of
approximately 30% [3]. For the fetus, GDM poses an increased
risk of stillbirth, perinatal complications, macrosomia and
growth restriction [4], and there is a greater predisposition to
type 2 diabetes, obesity and metabolic and cardiovascular
diseases later in life [5, 6].
Pregnancy is a pro-diabetogenic state due to changes in the
endocrine regulation of maternal carbohydrate and lipid
metabolism, which are essential for elevating circulating
blood glucose to meet fetal demands. Consequently, maternal
organs and peripheral tissues are adapted for glucose
intolerance and insulin resistance. As pregnancy advances,
the placenta is the major driver of these maternal metabolic
adaptations [7]. Although widely recognised as an organ of
nutrient and gaseous exchange, the placenta secretes an array
of polypeptide hormones, growth factors, cytokines and
adipokines that modulate maternal metabolism and fetal
growth. Human placental lactogen (hPL) and prolactin induce
beta cell expansion and insulin release in the maternal pancre-
as [8], while human placental growth hormone (hPGH) and
adipokines cause peripheral insulin resistance [9]. Maternal
serum concentrations of hPL and hPGH increase up to
30- and eightfold, respectively, during pregnancy [10]. The
placenta also secretes leptin, regulated by a placenta-specific
upstream enhancer [11], and adiponectin [12] for regulation of
maternal lipid metabolism, favouring fatty acids as a fuel
source in maternal tissues. In normal pregnancy, these factors
act in concert to redistribute maternal energy resources,
increasing their availability for the fetus. However,
perturbation of placental function potentially disrupts their
bioactivity, altering the normal balance of maternal
metabolism and resulting in GDM.
Organs with high polypeptide endocrine activity, such as
the pancreas and placenta, are susceptible to endoplasmic
reticulum (ER) stress. The ER coordinates the biosynthesis
and post-translational modification of secreted proteins and
membrane receptors, as well as maintaining calcium
homoeostasis in cells. Therefore, any perturbation of the ER
intraluminal environment can severely affect the bioactivity of
secreted proteins. Accumulation of misfolded proteins in the
ER provokes activation of an integrated network of signalling
pathways known as the unfolded protein response (UPR).
These pathways aim to restore ER homeostasis and involve
protein kinase RNA-like ER kinase (PERK)–eukaryotic
initiation factor 2 subunit α (eIF2α), which attenuates
non-essential protein synthesis, and ATF6 (activating
transcription factor 6) and inositol-requiring enzyme 1
(IRE1)–X-box binding protein 1 (XBP-1), which promote
the synthesis of ER-resident chaperones to increase folding
capacity. If these pathways fail to restore homeostasis,
apoptosis is activated to eliminate the damaged cells [13].
Research on the role of ER stress in human diabetes has
advanced rapidly and targeting to ameliorate ER stress has
become a therapeutic intervention [14]. In type 2 diabetes,
ER stress-induced dysfunction of pancreatic beta cells reduces
insulin production as well as its bioactivity, resulting in
hyperglycaemia [15]. The current view is that GDM is a
pre-diabetic state and, although there may be several underly-
ing causes, the majority of cases appear to be due to
pre-existing low-grade chronic beta cell dysfunction [16].
Consequently, insufficient insulin is secreted to overcome
the pregnancy-induced insulin resistance in the maternal
organs/peripheral tissues [17].
We have demonstrated the central role of placental ER
stress in the pathophysiology of pregnancy complications,
including fetal growth restriction and early-onset pre-eclamp-
sia [18, 19]. In this study, we first investigate evidence of ER
stress in placentas from women with GDM. We then use an
in vitro trophoblastic-like cell model to elucidate the mecha-
nisms by which hyperglycaemia may induce placental ER
stress. Finally, we examine the ability of chemical chaperones
and antioxidants to mitigate ER stress in trophoblast-like cells
under high glucose concentrations.
Methods
Materials All chemicals were purchased from either
Sigma-Aldrich (Dorset, UK) or Fisher Scientific UK
(Loughborough, UK) except where otherwise stated.
Antibodies against p-eIF2α (Ser51), eIF2α, calreticulin and
protein disulphide isomerase (PDI) were from Cell Signalling
Technology (NEB, Hitchin, UK). Antibodies against XBP-1
Diabetologia (2016) 59:2240–2250 2241
and glucose related protein (GRP) 94 were from Abcam
(Cambridge, UK), anti-Desmoplakin 1/2 was from AbD
Serotec (Oxford, UK), anti-GRP78 was from Transduction
Laboratories (BD Biosciences, Oxford, UK), and
anti-β-actin was from Sigma-Aldrich. All antibodies were
used according to manufacturer’s instruction except where
otherwise stated.
Participant selection and placental tissue collection
Placental samples were obtained from Oslo Pregnancy
Biobank at Oslo University Hospital, Norway (www.oslo-
universitetssykehus.no/opb). Twenty-one placentas from
singleton pregnancies were delivered by non-laboured
elective Caesarean section. The study was approved by the
South-Eastern Norway Regional Committee for Medical and
Health Research Ethics and informed consent was obtained
from all participants.
Pregnant women with (n=11) and without (n=10) GDM
were originally recruited onto the study. GDM participants
had 2 h serum glucose levels > 9.0 mmol/l following a 75 g
oral glucose tolerance test. GDM participants were treated by
diet, and insulin was started if necessary, based on clinical
indication. The control group (‘Control 1’) was free from
pre- and post-gestational diseases (including chronic diseases
and pregnancy complications), and had healthy pregnancy
outcomes. Thirty per cent of individuals in Control 1 had a
pre-gestational BMI >25. A second control group (‘Control
2’ ; n = 8) was also recruited for comparison with
normoglycaemic individuals with overweight/obesity (n=7).
All participants in Control 2 had a pre-gestational BMI <25
and, as with Control 1, were free from pre- and post-
gestational diseases and had healthy pregnancy outcomes.
HbA1c measurements were performed at standardised inter-
vals during the participant’s pregnancy, in keeping with the in-
stitution’s guidelines for antenatal follow-up of diabetes in preg-
nancy. Capillary samples were collected from participants using
Accu-chek Safe-T-pro Plus lancets (Roche Diagnostics,
Indianapolis, IN, USA) and added to a reagent kit for whole
blood (DCA Systems Hemoglobin A1c Reagent Kit, Siemens
Healthcare Diagnostics, Tarrytown, NY, USA). The HbA1c con-
centration was analysed in the clinic (‘at point of care’) using the
Siemens/Bayer DCA 2000+ Analyzer from 2001–2013
(replaced by Siemens DCA Vantage Analyzer as of 2014
[Global Division, Siemens Healthcare Diagnostics, Tarrytown,
NY, USA; see www.siemens.com/diagnostics]). To convert
values for HbA1c in % (National Glycohemoglobin
Standardization Program [NGSP] units) into mmol/mol
(International Federation of Clinical Chemistry and Laboratory
Medicine [IFCC] units), subtract 2.15 and multiply by 10.929.
In all participants, gestational age was determined during
pregnancy by ultrasound scanning between 17 and 20 weeks
of gestation and all participants delivered at the same gesta-
tional stage. Placental samples were processed immediately
following delivery. Biopsies were selected from a macroscop-
ically normal-looking, centrally located lobule, avoiding the
decidual and membrane layers. Samples were snap-frozen in
liquid nitrogen and stored at −80°C. All samples were
analysed on a non-blinded basis.
Generation of a new line of BeWo cells, BeWo-NG BeWo
cells were a gift from Professor Charnock-Jones (Department
of Obstetrics and Gynaecology, University of Cambridge, UK)
and were verified using a panel of markers for trophoblast cells
[20]. They were not tested for Mycoplasma contamination.
BeWo cells are routinely cultured in medium with a high
concentration of glucose, such as DMEM/F12 (containing
17.1 mmol/l glucose). This non-physiological hyperglycaemic
environment renders these cells inappropriate for any glucose-
related study. Therefore, a new line, BeWo-NG, was generated
by culturing cells in the physiological glucose concentration of
5.5 mmol/l in modified DMEM/F12 medium, which was
prepared by adding 0.99 g of glucose into 1 l of glucose-free
DMEM/F12 medium (US Biological, Salem, MA, USA).
Details are described in the ESM Methods; ‘Generation of
new line of BeWo cells, BeWo-NG and culturing conditions’.
After 20 passages, the BeWo-NG cells showed no difference in
proliferation rate compared with parental BeWo cells (ESM
Fig. 1a). Treatment with 10 μmol/l forskolin A induced
syncytialisation as indicated by loss of Desmoplakin staining
using anti-human Desmoplakin 1/2 antibody (AbD Serotec,
Oxford, UK) and production of human chorionic gonadotro-
phin (ESM Fig. 1b, c). Details of Desmoplakin 1/2 immuno-
cytochemical staining are described in ESM. These results
confirmed that the BeWo-NG cells retained properties similar
to those of the parental BeWo cells.
Western blot analysis The levels of total and phosphorylated
proteins and kinases were measured by western blotting as
described in the ESM Methods. All antibodies were used at
a 1:1000 dilution except GRP78 andβ-actin, which were used
at a 1:10,000 dilution. All primary antibodies were diluted in
Tris-buffered saline (TBS) containing 0.1% (vol./vol.) Tween
20 and incubated overnight at 4°C, followed by a few hours at
room temperature. The antibodies for ER and oxidative stress
markers were validated with cell lysates prepared from the
cells treated with either ER stress inducers (tunicamycin
[Sigma-Aldrich] and thapsigargin [Sigma-Aldrich]) or expo-
sure to repetitive hypoxia-reoxygenation, as shown in previ-
ous publications [18, 24].
Measurement of pH The pH of media was determined using
a pH meter (JENCO model 60, Lazar Research Laboratories,
Los Angeles, CA, USA) connected to a micro pH electrode
(Lazar Research Laboratories). Each experimental condition
was performed in duplicate.
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Lactate assay Lactate accumulation in the culture media was
evaluated enzymatically in hydrazine/glycine buffer (pH 9.2),
containing 5 mg/ml β-NAD+ and 30 U/ml lactate dehydroge-
nase to a final volume of 1 ml [21]. The reaction was started
by addition of a sample. The change in absorbance because of
NADH formation was monitored for 4 min at 340 nm using a
Helios α UV-VIS spectrophotometer (Unicam, Cambridge,
UK). A lactate calibration curve ranging from 10 to
150 μmol/l was constructed and used to calculate lactate
concentrations in samples.
Electron microscopy Samples from normal and GDM
placentas were fixed immediately after delivery in 2.5%
glutaraldehyde (wt/vol.) in 0.1 mol/l cacodylate buffer for
4 h, post-fixed in 1% osmium and then embedded in
Araldite resin. Thin sections were stained with lead citrate
and uranyl acetate, and viewed using a Philips CM100 micro-
scope (FEI, Hillsboro, OR, USA). All chemicals were
purchased from TAAB Laboratories Equipment (Berks, UK)
Statistical analysis Statistical analyses were performed in
GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA,
USA). Differences were tested using the non-parametric
Mann–Whitney U test or parametric Student’s t test, with
p<0.05 being considered significant. For multiple compari-
sons, differences were tested using non-parametric Kruskal–
Wallis test, followed by Dunn’s multiple comparisons test.
Results
The GDM and control groups were similar regarding gesta-
tional age at delivery and maternal age (Table 1).
Pre-pregnancy and delivery maternal BMI, were significantly
higher in the GDM group than in the control group, whereas
birthweights and placental weights were not significantly dif-
ferent. All GDM patients showed elevated levels of HbA1c
(5.86±0.55% or 40.64±5.85 mmol/mol, n=11), indicating
chronic hyperglycaemia. Although the HbA1c level was not
measured in the control group, a previous study reported a
value of approximately 5% or 31 mmol/mol in the third
trimester of normal pregnancy [22].
Low-grade ER stress is increased in GDM placentas
Electron microscopy revealed mild to moderate dilatation of
the ER cisternae, a hallmark of ER stress, in the
syncytiotrophoblast of placentas from GDM pregnancies
compared with normoglycaemic controls (Fig. 1a). The nor-
mal ER cisternae and mitochondrial cristae in the
cytotrophoblast and endothelial cells confirmed that these ap-
pearances were not fixation artefacts (Fig. 1a).
To assess the severity of ER stress in the GDM placentas,
the activity of the PERK, ATF6 and IRE1 pathways was
monitored by examining their corresponding downstream ef-
fectors. Results revealed an increase of >8 in phosphorylation
of eIF2α (p-eIF2α; Fig. 1 b, c), but no evidence of splicing of
XBP-1. There was, however, a ∼1.2-fold elevation of the full-
length XBP-1(FL) protein translated from the unspliced XBP-
1 mRNA. The correlation between levels of p-eIF2α and
HbA1c did not reach statistical significance (p-eIF2α,
p=0.079, Fig. 1d). ATF6 is processed by specific proteases
to generate a potent ATF6(p50) transcription factor [16].
Although the ATF6α antibody used recognises both the full-
length ATF6α(p90) and the active form (ATF6α[p50]) only
the active form was detected (Fig. 1c). The level of
ATF6α(p50) in the GDM placentas showed no significant
difference (p = 0.09) compared with control placentas.
Furthermore, the downstream targets of ATF6α(p50),
GRP78 and GRP94, were unchanged compared with the
controls. To summarise, both ultrastructural analysis and ER
molecular markers demonstrate the existence of mild ER
stress in placentas from GDM pregnancies.
Women with GDM had a pre-pregnancy BMI significantly
higher than that of women in the control group, Control 1
(Table 1). Therefore, we investigated the contribution of obesity
in the activation of placental ER stress. To allow for comparison
with a solely non-obese control group, a second control group
comprising placentas from non-obese women (BMI <25) with
normal pregnancies (Control 2) was also collected. The pre-
pregnancyBMI of the overweight/obesewomenwas significant-
ly higher than that of Control 2 (29±1 vs 21±0.2 kg/m2,
p=0.0004) and was comparable with that of all GDM cases
(30.6±1.3 kg/m2; Table 1). Immunoblotting revealed there to
be no significant change in ER stress markers p-eIF2α and
GRP78 in the overweight/obese women (ESM Fig. 2a, b).
However, the expression of XBP-1, which was increased in the
GDM placentas, was significantly reduced (ESM Fig. 2b).
Additionally, there was no correlation between the p-eIF2α level
in the placentas and maternal BMI in GDM (ESM Fig. 2c). To
conclude, these results exclude the possibility of the in-
creased ER stress in GDM placenta arising from maternal
obesity.
High glucose does not directly activate ER stress in
trophoblast-like cells To elucidate whether the placental ER
stress observed in GDM pregnancies is the result of maternal
hyperglycaemia, an in vitro model using trophoblast-like cells
treated with high concentrations of glucose was introduced.
As ER stress was observed solely in the syncytiotrophoblast,
BeWo-NG cells were treated with forskolin A to induce dif-
ferentiation into syncytial masses prior to experimentation.
BeWo-NG cells adapted to a 5.5 mmol/l physiological glu-
cose concentration were challenged with 10 and 20 mmol/l
glucose for 24 h. The high glucose treatments induced an over
sixfold elevation of p-eIF2α (Fig. 2a). However, other ER
stress markers, GRP78, GRP94 and XBP-1(FL), and the ER
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residential proteins protein disulfide isomerase (PDI) and
calreticulin, appeared to be unchanged (Fig. 2b).
A change of the pH indicator (Phenol Red) in the modified
DMEM/F12 medium suggested that the high glucose concen-
trations caused metabolic acidosis. Indeed, while the mean pH
of the 5.5 mmol/l glucose medium dropped from 7.0 to 6.8
after 24 h, in both the 10 and 20 mmol/l glucose media it was
reduced to ∼6.2 (Fig. 2c). These reductions in pH were par-
tially a result of lactate accumulation as there was a ∼23% and
∼15% increase in lactate in the media containing 10 and
20 mmol/l glucose, respectively (Fig. 2d).
To determine whether metabolic acidosis, per se, can in-
duce ER stress, the volume of the mediumwas increased from
2 to 3 ml to dilute the metabolites. As a consequence, the pH
of the media containing 10 and 20 mmol/l glucose was par-
tially restored to ∼6.6 (Fig. 2c). Phosphorylation of eIF2αwas
greatly decreased (Fig. 2b), while levels of all other ER stress
markers and residential proteins remained unchanged. To
summarise, these results suggest that high glucose is unlikely
to be a direct inducer of ER stress.
High glucose-induced acidosis triggers mild ER stress in
trophoblast-like cells To further explore the potential role of
metabolic acidosis in activation of ER stress in BeWo-NG
cells, two approaches were introduced. First, an extra
15 mmol/l of sodium bicarbonate (NaHCO3) was added to
the culture medium, raising the concentration from 14 to
29 mmol/l, to increase its buffering capacity. This caused the
basal pH value to rise to ∼7.5 (Fig. 2c). After incubation for
24 h the pH of all the media with added NaHCO3 were sig-
nificantly higher than the pH of media without the added
NaHCO3 (Fig. 2c). In the 10 and 20 mmol/l glucose media,
the values were ∼7.0. Restoration of the pH reduced p-eIF2α
by ∼threefold (Fig. 2f), while levels of other ER stress
markers and residential proteins appeared to remain constant
(Fig. 2e).
Next, BeWo-NG cells were exposed for 1–6 h to media
containing 5.5 mmol/l glucose with different acidities, ranging
from pH 5.5 to 7.0. Culture for up to 6 h did not alter the pH
values in the media, eliminating the possibility of any effect
from accumulating metabolites (data not shown). Media with
a pH higher than 6.5 did not induce ER stress (Fig. 2g). There
was a time-dependent increase in p-eIF2α in medium with a
pH of 6.0, but other ER stress markers remained constant. In
medium of pH 5.5, p-eIF2α was increased strongly after only
3 h, and the level of XBP-1(FL) rose after 6 h (Fig. 2g). Phase-
Table 1 Clinical characteristics of the participants according to study group
Characteristic Control 1 (n = 10) GDM (n= 11) Control 2 (n= 8) Non-GDM
overweight/obese
(n = 7)
p value
(ANOVA)
Maternal age (years) 32 ± 1.5 34.3 ± 1.4 33.5 ± 2.4 33.7 ± 0.5 NS
Gestational age (weeks) 38.1 ± 0.2 38.9 ± 0.4 38.8 ± 0.2 39± 0.2b 0.013
Birthweight (g) 3582± 104 4195 ± 239 3595± 136 3830± 181 NS
Placental weight (g) 647 ± 52 767 ± 74 661 ± 62 680 ± 109 NS
Pre-pregnancy BMI (kg/m2) 22.8 ± 1.2 30.6 ± 1.3a, 21 ± 0.2 29± 1.0b 0.0004
Rate of pre-pregnancy overweight/obesity (%)
BMI ≥ 25 kg/m2 30 72.7 0 100
BMI ≥ 30 kg/m2 0 36.3 0 28.6
Delivery BMI (kg/m2) 29.1 ± 1.2 34.7 ± 0.9b 27.3 ± 1.1 33.1 ± 1.2 0.0065
Capillary HbA1c (late third trimester)
(%) 5c 5.86 ± 0.55 5c –
(mmol/mol) 31c 40.64 ± 5.85 31c
Intervention during GDM pregnancy (n)
Insulin + diet – 5 – –
Diet – 6 – –
Values are expressed as mean ± SEM, unless stated otherwise
The ‘Control 1’ cohort is the initial normoglycaemic control group, containing 30% overweight/obese women with a pre-pregnancy BMI> 25. ‘Control
2’ is a second normoglycaemic control group of non-obese women with a pre-pregnancy BMI < 25
‘Overweight/obese GDM’ comprise of a subset of ‘GDM’ participants
Differences were tested using the non-parametric Kruskal–Wallis test, followed by Dunn’s multiple comparisons test
a Statistically significant compared with Control 1
b Statistically significant compared with Control 2
c HbA1c was not measured in normal pregnancies; reference values during the third trimester were those measured by Neilsen et al [21]
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contrast microscopy examination revealed condensed nuclei
and loss of membrane integrity; potential signs of necrosis
(data not shown). A marked reduction of the ER residential
proteins PDI and calreticulin (Fig. 2g), and of the cytosolic
protein p38 kinase (ESM Fig. 3a), confirmed that the cells
were losing both ER and plasma membrane integrity under
these conditions.
To summarise, these findings suggest that exposure to
a low pH can alter ER homeostasis, thereby activating
the UPR.
ER molecular chaperones and antioxidants suppress high
glucose-induced ER stresses Chemical chaperones, includ-
ing 4-phenylbutyrate (4-PBA) and tauroursodeoxycholic acid
(TUDCA), have been widely demonstrated to be effective in
reducing ER stress [23], while antioxidants, such as vitamins
C and E, suppress oxidative stress in placental explants [24].
Therefore, we investigated the effects of chemical chaperones
and antioxidants in the suppression of high glucose-induced
ER stress. Both chemical chaperones and antioxidants were
effective in reducing phosphorylation of eIF2α (Fig. 3a, b),
while all other ER stress markers and residential proteins
remained unchanged (Fig. 3a). Surprisingly, vitamins, but
not chemical chaperones, significantly restored the pH of the
normal media to ∼6.7 and reduced lactate accumulation by
over 50% in the presence of 10 and 20 mmol/l glucose
(Fig. 3c, d). Vitamin C or vitamin E alone suppressed high
glucose-induced ER stress and restored the pH, but were not
as effective when combined (data not shown). These results
reveal potential beneficial effects of both chemical chaperones
and vitamins C and E in reducing ER stress. Additionally, not
only can the vitamins suppress the ER stress induced by high
glucose but they may also be used to prevent hyperglycaemia-
induced acidosis.
Fig. 1 Low-grade ER stress in
the GDM placentas. (a) Electron
micrographs showing dilated ER
cisternae (arrows) in the
syncytiotrophoblast (SynT) but
not in the cytotrophoblast (CT) or
endothelial cells (EC). FV, fetal
vessel. Magnification ×5000. (b)
Representative blots of p-eIF2α,
eIF2α, ATF6α, unspliced XBP-1
(XBP-1(FL)), GRP94 and
GRP78. β-actin was used as
loading control. (c) Quantification
of the band intensity from (b).
The y-axis shows the relative
level of phosphorylated or total
protein. Phosphorylation status of
eIF2α is presented as the ratio
between phosphorylated and total
protein. All protein levels are
normalised to β-actin. Data are
presented as mean ± SEM, n= 10
or 11; *p< 0.05; **p < 0.01 vs
control. (d, e) Correlation
between HbA1c and (d) p-eIF2α
and (e) XBP-1(FL). In (d, e), the
concentration of HbA1c was
plotted against relative ratio of
p-eIF2α or XBP-1(FL) and a
linear regression line added
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Fig. 2 ER stress induced by high glucose is mediated by metabolic
acidosis. BeWo-NG cells were cultured in serum-free media containing
5.5, 10 and 20 mmol/l glucose in combination with various experimental
conditions for 24 h. ER stress markers were measured by western blot-
ting, with β-actin or Ponceau S staining as loading control. (a)
Phosphorylation of eIF2α under different glucose concentrations
(mmol/l). The y-axis shows the relative level of p-eIF2α, eIF2α and the
ratio of p-eIF2α/eIF2α. **p < 0.01 vs 5.5 mmol/l glucose. (b)
Representative blots showing effect of changing medium volume on
phosphorylation of eIF2α. Cells were treated with different glucose con-
centrations (mmol/l) in 2 ml (control) or 3 ml incubation volume. (c)
Effect of changingmedium volume and buffering capacity on pH induced
by high glucose (10 or 20 mmol/l). **p < 0.01 vs 5.5 mmol/l glucose
within the 2 ml glucose-only control group; ††p < 0.01 vs 10 mmol/l
glucose in the 2 ml glucose-only control group; ‡‡p< 0.01 vs 20 mmol/l
glucose in the 2 ml glucose-only control group. (d) Lactate production in
high glucose medium. *p < 0.05 and **p< 0.01 vs 5.5 mmol/l glucose.
(e) Representative western blots showing phosphorylation of eIF2α in
relation to medium buffering capacity. Cells were cultured with different
glucose concentrations (mmol/l) in the presence or absence of additional
NaHCO3 (15 mmol/l) for 24 h. (f) Quantification of p-eIF2α with or
without NaHCO3. The y-axis shows the relative level of p-eIF2α and
eIF2α and the ratio of p-eIF2α/eIF2α. **p < 0.01 for presence vs absence
of NaHCO3 at the same glucose concentration. (g) Effect of acidified
culture media on induction of ER stress. The pH of the culture medium
containing 5.5 mmol/l glucose was adjusted to 7, 6.5, 6 and 5.5, and the
BeWo-NG cells were exposed to these media for 1, 3 or 6 h. Data are
presented as mean ± SEM or as immunoblot images, n= 3–6
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Discussion
In this study, we provide the first evidence for the existence of
placental ER stress in women with established GDM, as
demonstrated by dilatation of ER cisternae in the
syncytiotrophoblast and increased p-eIF2α and unspliced
XBP-1 protein. Evidence for activation of the IRE1α arm
remains elusive because of inconsistent signals from the
downstream effectors, with no splicing of XBP-1, but poten-
tial activation of the TNF receptor-associated factor 2
(TRAF2)–c-Jun N-terminal kinase (JNK) pathway (ESM
Fig. 4). To conclude, the results suggest that placental ER
stress in GDM is mild compared with that observed in preg-
nancies complicated by fetal growth restriction and early-
onset pre-eclampsia [18, 25]. It must be remembered, howev-
er, that the GDM placentas studied came from women whose
glucose levels were well-controlled, as evidenced by mean
HbA1c levels which were only just outside the normal range.
The severity of placental pathology in individuals with diabe-
tes is generally related to the quality of glucose control [26].
To test whether elevated glucose concentrations per se are
able to induce ER stress, we developed a new trophoblast-like
cell line adapted to physiological glucose concentrations,
BeWo-NG. Use of these cells revealed that high glucose
concentrations induce ER stress in vitro, most likely through
metabolic acidosis. Activation of the UPR was limited to the
PERK signalling arm. Severe acidosis induces ER stress in
other cell types [27]. Although the mechanisms are elusive,
the activity of Ca2+-ATPases is susceptible to acidosis and
there is a pH-dependent Ca2+ efflux from the intracellular
storage compartments. Acidification of the medium (from
pH 7.0 to 6.5) causes release of Ca2+ from the ER and loss
of ER homeostasis [28], activating the UPR. Lactic acid has
been demonstrated to induce phosphorylation of eIF2α in
cancer cells, possibly through this mechanism [29]. In
GDM, excessive maternal blood glucose could facilitate
Fig. 3 Both chemical chaperones
and antioxidants effectively
suppress high glucose-induced
ER stress, but only antioxidants
reduce the degree of metabolic
acidosis. BeWo-NG cells were
treated with different
concentrations of glucose in the
presence of either chemical
chaperones, 4-PBA (500 μmol/l)
and TUDCA (250 μmol/l), or
vitamin C (Vit C; 500 μmol/l) or
vitamin E (Vit E; 500 μmol/l) for
24 h. (a) Levels of ER stress
markers were determined by
western blotting. β-actin was
used as loading control. (b)
Phosphorylation status is
presented as the ratio between
phosphorylated and total protein.
Data are presented as mean
± SEM, n = 3. The y-axis shows
the relative level of p-eIF2α
eIF2α or the ratio of p-eIF2α/
eIF2α. (c) pH of the culturemedia
after the experiment. (d) Effect of
vitamins on high glucose-induced
lactate production. Data are
presented as median, n= 3–6.
†p < 0.05 and ††p < 0.01 vs
10 mmol/l glucose in the glucose-
only control group; ‡p< 0.05 and
‡‡p< 0.01 vs 20 mmol/l glucose
in the glucose-only control group
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overproduction of lactate in the placenta, resulting in metabol-
ic acidosis. Unlikemany organs, in which lactate production is
usually under hypoxic conditions, the placenta synthesises
considerable quantities of lactate under aerobic conditions
[30].
The human placenta expresses all five isozymes of lactate
dehydrogenase, which catalyses the inter-conversion of lactate
and pyruvate in the glycolytic pathway [31]. The activity of
only one of the five isozymes is increased in trophoblast cells
upon hypoxia [30], suggesting that the majority of the placental
isozymes may facilitate lactate production aerobically. The
amount of lactate produced by the placenta is directly propor-
tional to the maternal glucose concentration, as elevation of the
glucose concentration from 4.2 to 10.9 mmol/l during placental
perfusion in vitro induced a fourfold increase in lactate produc-
tion. However, raising the glucose concentration further had no
additional effect [32], consistent with our observation of no
change in the pH value of media containing 10 or 20 mmol/l
glucose. Unfortunately, data on placental lactate production
in vivo in GDM patients are not available. A study by
Taricco et al, using indirect measures, reported a 23% increase
of lactate concentration in the umbilical vein in GDM pregnan-
cies [33]. Hence, the placenta is likely producing more lactate
in GDM and transporting it to the fetus for metabolism.
An alternative explanation is that the placental ER stress
reflects the maternal pro-inflammatory environment associat-
ed with obesity [34], a potentially confounding variable as our
participants were not matched for pre-pregnancy BMI.
However, placentas from normoglycaemic obese women did
not show ER stress. Furthermore, adding palmitic acid to
BeWo-NG cells during a high glucose challenge did not ex-
acerbate the ER stress (ESM Fig. 2a, b, d), indicating that high
levels of fatty acids are unlikely to be a causative factor.
Finally, there was no correlation between the level of p-
eIF2α and the BMI of the women at the time of delivery
(ESM Fig. 2c). Together, these results suggest that obesity is
unlikely to be the cause of the placental ER stress observed in
GDM.
Oxidative stress is also a strong inducer of ER stress in the
trophoblast [35]. However, the existence of oxidative stress in
GDM placentas remains contentious as both increased and
unchanged stress have been reported [36, 37]. This may be
due to differences in the percentages of women under dietary
control (85% vs 53%) and insulin therapy (15% vs 47%).
Nevertheless, the GDM placentas used in this study (54% of
which were from those under dietary control) showed only a
mild level of oxidative stress as indicated by activation of
JNKs without significant changes in p38 kinase phosphoryla-
tion and heat shock proteins (ESM Fig. 4). We speculate that
placental ER and oxidative stress may occur to a greater extent
in GDM pregnancies with more severe metabolic acidosis.
Indeed, treating BeWo-NG cells with low-pH media
strongly activated the oxidative stress marker p38 kinase
phosphorylation (ESM Fig. 3a), similar to treatment
with high glucose concentrations (ESM Fig. 3b). These
results suggest that the oxidative stress observed in
GDM placentas may be triggered at least in part by
placental metabolic acidosis. Further studies are required
to confirm this hypothesis.
Finally, we demonstrated the potential use of chemical ER
chaperones and antioxidant vitamins as therapeutic interven-
tions to prevent glucose-induced placental ER stress.
Chemical chaperones had a similar efficacy to that of antiox-
idants in the suppression of ER stress at a glucose concentra-
tion of 10 mmol/l, but the chemical chaperones lost their ben-
eficial effects at a higher concentration of 20 mmol/l
(Fig. 3a, b). The exact mechanisms by which vitamins C and
E restore pH at high glucose concentrations are not known.
However, they are unlikely to be related to their antioxidant
properties, as other antioxidants (edaravone and N-acetyl-
L-cysteine) had no effect (data not shown). Nonetheless, both
vitamin C and vitamin E protect muscle cells from mitochon-
drial damage, including membrane rupture, during exhaustive
exercise, which is accompanied by lactate accumulation [38].
Therefore, the vitamins may maintain mitochondrial integrity
and function during metabolic acidosis, thereby reducing an-
aerobic lactate production. Indeed, our data in Fig. 3d showing
inhibition of lactate production support this speculation.
These results provide new insight into the potential use of
ER chaperones as therapeutic agents in diabetic pregnancies.
Additionally, vitamins C and E could be administered as
health supplements in conjunction with both dietary and insu-
lin control to mitigate the adverse effects of metabolic acidosis
on the placenta, thereby improving fetal wellbeing.
Furthermore, in a mouse model of diabetes, hyperglycaemia-
induced ER stress mediated embryopathy can be ameliorated
through administration of 4-PBA [39].
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